The GiACTA trial: Tocilizumab in giant cell arteritis
Stone et al. Trial of Tocilizumab in Giant-Cell Arteritis. N ...
Read More
Read More
Happy 4th anniversary!
Today is my anniversary! The fourth anniversary of my diagnosis. ...
Read More
Read More
WORKSHOP: The 19th International Vasculitis and ANCA Workshop – April 7th – 10th, 2019, Philadelphia, PA USA
Announcing the 19th International Vasculitis and ANCA Workshop. The Workshop ...
Read More
Read More
The MIRRA trial: Mepolizumab (Nucala) or placebo for the treatment of EGPA/Churg-Strauss Syndrome
Wechsler et al. Mepolizumab or Placebo for Eosinophilic Granulomatosis with ...
Read More
Read More
How do the IL-5 inhibitors Cinqair, Fasenra, and Nucala work?
The IL-5 inhibitors Cinqair (reslizumab), Fasenra (benralizumab), and Nucala (mepolizumab) ...
Read More
Read More
Tapers, treatments, and flares: My treatment course for EGPA/Churg-Strauss vasculitis (Oct 2014 – Apr 2018)
Fall down seven times, get up eight times. - Zen ...
Read More
Read More
Living with #raredisease EGPA: Eosinophilic Granulomatosis with Polyangiitis
When I got my diagnosis, at first, I was relieved. ...
Read More
Read More
Step one: My diagnosis with EGPA/Churg-Strauss vasculitis
Finally! A diagnosis! Then you realize that getting the diagnosis ...
Read More
Read More
Managing vasculitis: A patient’s perspective
Webinar recorded for the March 2017 - Vasculitis Foundation Road ...
Read More
Read More